Siemens' medical technology sales up 4% in first half:
This article was originally published in Clinica
Executive Summary
German company Siemens' medical engineering group reported turnover of DM 3,300 million ($2,200 million), in the first half of 1996, an increase of 4%. New orders have been hit by cost-cutting reforms in the public health sector in Germany, falling 1% to DM 3,500 million. Siemens' group turnover rose 6% to DM 42,300 million, primarily due to a 14% surge in international business. German sales declined 5% to DM 16,900 million.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.